Commercialising medical technology is no easy feat. As an inventor and founder, you not only need to develop your new device but also understand the entire pathway to its commercialisation.
That’s a big ask, as it includes regulatory approval and reimbursement strategies for each geography you want to enter. Once you get to market, you must ensure your data differentiates you enough from your competitors so you can quickly gain market share and drive revenue growth.
Having the right partners can not only ease the process but also significantly enhance the chances of success in the shortest possible timeline.
At Podymos, we’ve collaborated with many of these partners and know clients who have been pleased with their work, so we wanted to create a list in case they can be of help to you in your journey.
Clin R+
EU MDR regulatory submission and clinical development plan creation
Clin R+ offers a focused approach to regulatory approval, providing consulting services specifically for medical device and IVD manufacturers. They assist in areas such as intended purpose development, clinical planning and study design, reimbursement assessment, and writing of regulatory technical documents.
For more information or to get in touch, visit Clin R+.
Services include intended purpose, clinical development plan and study design, reimbursement assessment, technical document creation and submission.
Device Access
UK market access & health economics
Navigating the UK healthcare market requires specific expertise. Device Access provides support to MedTech companies who want to understand the true value of their technology. They do this through health economics and care pathway analysis, showing how your technology impacts the patient, the provider, and the payer at each stage of the pathway.
When done early enough in the commercialisation journey, this will help you to set the true price of your technology based on the value it offers healthcare systems, versus what the competition currently charges.
In addition, Device Access is a NICE META Tool Facilitator and has supported over 50 companies to successfully navigate their journey to NICE recommendation through various NICE MedTech programmes.
For further details, visit Device Access.
Services include: technology value analysis, NICE META Tool Facilitator, health economic and outcome research (HEOR), market access strategy planning, economic evidence development, systematic reviews.
PRIA Healthcare
US reimbursement
PRIA Healthcare is US-based and positions itself as an advocate for the consistent and reliable reimbursement of advanced medical devices, procedures, and treatments. With expertise in early reimbursement strategy, clinical trial reimbursement programs, and patient access programs, PRIA Healthcare aims to enhance the market success of novel medical device procedures in the US.
They offer solutions to define reimbursement pathways for new products, support third-party clinical trial reimbursement, and facilitate patient access to new medical device procedures. This is especially crucial for medical device companies navigating the intricacies of coding, coverage, and payment for innovative procedures.
For more insights, visit PRIA Healthcare.
Services include: strategic reimbursement, clinical trial reimbursement, patient access, reimbursement hotline services, payer engagement.
Bird & Bird
Intellectual property law
Bird & Bird is an international law firm with a strong emphasis on assisting clients from various sectors, including the MedTech industry. Their expertise spans across multiple legal areas, but for MedTech start-ups, their services in intellectual property (IP) law can be particularly invaluable. Protecting innovations from potential infringements is crucial, and Bird & Bird offers guidance in ensuring that intellectual assets are safeguarded.
Their global reach and extensive experience make them a reliable partner for start-ups looking to navigate the complexities of IP law.
For more information, visit Bird & Bird.
Services include: IP law
Gloucester Road Communications
Public relations
Gloucester Road Communications is a boutique PR firm that focuses solely on MedTech.Amanda Hayhurst, the founder of Gloucester Road Communications, has achieved notable media coverage for many early-stage MedTech companies that we’ve worked with.
As Amanda is a consultant, she does not have a website, but she can be contacted via her email: amanda@amandahayhurst.com
Services include: the development and execution of PR strategy
A growing list
We’re going to continue adding to this list as we work with new teams that have provided significant value to our clients, so stay tuned…
Steer your commercialisation journey in the right direction (h2)
The MedTech landscape is vast and ever-evolving. As start-ups strive to bring their innovations to the forefront, the importance of collaboration cannot be overstated.
The journey from ideation to commercialisation is filled with potential missteps, which can lead to significant setbacks in timelines and budget.
By aligning with knowledgeable partners, start-ups can mitigate risks, streamline processes, and ultimately amplify their impact in the healthcare sector. Remember, success in MedTech isn’t just about groundbreaking technology; it’s also about great strategic planning from the start.